Biomedical Engineering Reference
In-Depth Information
Those agents not listed in Risk Groups (RGs) 2, 3, and 4 are not automati-
cally or implicitly classified in RG1; a risk assessment must be conducted
based on the known and potential properties of the agents and their relation-
ship to agents that are listed.
Appendix B-II: Risk Group 2 (RG2) Agents
RG2 agents are associated with human disease that is rarely serious and for
which preventive or therapeutic interventions are often available.
Appendix B-II-A: Risk Group 2 (RG2)—
Bacterial Agents Including Chlamydia
Acinetobacter baumannii
(formerly
Acinetobacter calcoaceticus
)
Actinobacillus
Actinomyces pyogenes
(formerly Corynebacterium pyogenes)
Aeromonas hydrophila
Amycolata autotrophica
Archanobacterium haemolyticum
(formerly
Corynebacterium haemolyticum
)
Arizona hinshawii
—all serotypes
Bacillus anthracis
Bartonella henselae, B. quintana, B. vinsonii
Bordetella including B. pertussis
Borrelia recurrentis, B. burgdorferi
Burkholderia (formerly Pseudomonas species) except those listed in
Appendix B-III-A (RG3))
Campylobacter coli, C. fetus, C. jejuni
Chlamydia psittaci, C. trachomatis, C. pneumoniae
Clostridium botulinum, Cl. chauvoei, Cl. haemolyticum, Cl. histolyticum, Cl.
novyi, Cl. septicum, Cl. tetani
Corynebacterium diphtheriae, C. pseudotuberculosis, C. renale
Dermatophilus congolensis
Edwardsiella tarda
Erysipelothrix rhusiopathiae
Escherichia coli
—all enteropathogenic, enterotoxigenic, enteroinvasive
and strains bearing K1 antigen, including
E. coli
O157:H7
